Contact
Please use this form to send email to PR contact of this press release:
PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
TO:
Please use this form to send email to PR contact of this press release:
PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
TO: